Ads
related to: when to treat hyperphosphatemia meaning in pregnancy treatment schedule- Phosphate Binder FAQs
Get Answers To Frequently Asked
Phosphate Binder Questions.
- How The Treatment Works
Learn How A Phosphate Binder
Treatment Works - Watch A Video.
- Impact Of High Phosphorus
Learn More About The Impact
Of High Phosphorus Levels.
- Savings Information
Download A Savings Card For A
Phosphate Binder Treatment Option.
- Dialysis Patient Support
Read Helpful Resources & Visit An
Official Phosphate Binder Site.
- Your Guide To Phosphorus
Download The Patient Guide
To Learn More About Phosphorus.
- Phosphate Binder FAQs
Search results
Results From The WOW.Com Content Network
Hyperphosphatemia. Hyperphosphatemia is an electrolyte disorder in which there is an elevated level of phosphate in the blood. [1] Most people have no symptoms while others develop calcium deposits in the soft tissue. [1] The disorder is often accompanied by low calcium blood levels, which can result in muscle spasms.
Sucroferric oxyhydroxide. Sucroferric oxyhydroxide, sold under the brand name Velphoro, is a non-calcium, iron-based phosphate binder used for the control of serum phosphorus levels in adults with chronic kidney disease (CKD) on haemodialysis (HD) or peritoneal dialysis (PD). [6] It is used in form of chewable tablets.
Sevelamer (rINN) is a phosphate binding medication used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is marketed by Sanofi under the brand names Renagel (sevelamer ...
RenaZorb is an orally available, lanthanum-based nanotechnology compound being developed for the potential treatment of high phosphate blood levels in patients with Stage 5 chronic kidney disease
Prenatal care in the United States is a health care preventive care protocol recommended to women with the goal to provide regular check-ups that allow obstetricians-gynecologists, family medicine physicians, or midwives to detect, treat and prevent potential health problems throughout the course of pregnancy while promoting healthy lifestyles that benefit both mother and child. [1]
Based on a survey conducted in 2022, Nephrologists stated that the greatest unmet need in the treatment of hyperphosphatemia with phosphate binders is a lower pill burden and better patient compliance. 1 The global market opportunity for treating hyperphosphatemia is expected to exceed $2.5 billion, with the United States accounting for more ...
A heterotopic pregnancy is a complication of pregnancy in which both extrauterine (ectopic) pregnancy and intrauterine pregnancy occur simultaneously. [2] It may also be referred to as a combined ectopic pregnancy, multiple‑sited pregnancy, or coincident pregnancy. The most common site of the extrauterine pregnancy is the fallopian tube.
A high-risk pregnancy is a pregnancy where the mother or the fetus has an increased risk of adverse outcomes compared to uncomplicated pregnancies. No concrete guidelines currently exist for distinguishing “high-risk” pregnancies from “low-risk” pregnancies; however, there are certain studied conditions that have been shown to put the mother or fetus at a higher risk of poor outcomes. [1]
Ad
related to: when to treat hyperphosphatemia meaning in pregnancy treatment schedule